Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202621811> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W3202621811 endingPage "S1140" @default.
- W3202621811 startingPage "S1139" @default.
- W3202621811 abstract "There are not specific information about otucomes of COVID-19 infection in patients with breast cancer. We aimed to describe the outcomes in this population in our national cohort of patients with cancer and infection for COVID-19. ACHOCC-19B registry is a multicenter observational study composed of a cross-sectional and a prospective cohort component. Eligibility criteria were the diagnosis of breast cancer and COVID-19 infection confirmed with RT-PCR. Follow-up of 30 days was completed. Clinical data were extracted of the multicentric register of cancer and covid-19 in Colombia (ACHOCC-19), collected from Apr 1 until Oct 31, 2020. The primary outcome was 30-day mortality from all causes and secondary outcome was asymptomatic disease. Associations between demographic or clinical characteristics and outcomes were measured with odds ratios (ORs) with 95% CIs using multivariable logistic regression. 132 patients were included(18,5% of global ACHOCC-19 cohort). 18,2% died and 25,8% was asymptomatic. In relation to the patients who died vs did not died, 68 vs 66% were > 50 years, 20 vs 10,2% with obesity, 32 vs 51,4% without comorbidities: 24 vs 12% with Diabetes, 56 vs 29% arterial Hypertension, 17,75 vs 3.88% ECOG >2, 50 vs 12,5% progressive cancer, 20 vs 5,6% bacterial coinfection, 65 vs 25,2% received antibiotic and 68 vs 19% steroids for Covid-19 infection. 11.3% had severe infection and received ventilatory support and 66% died. About the asymptomatic patients 74% were > 50 years, 2,9% had obesity, 56% without comorbidities, 56% with ECOG 0 and 17,6% had metastatic disease. In the logistic regression analysis, age > 50 years (OR 2,7 95% 0,54-13,81), >2 comorbidities (OR 3,48 95% 0,26-45,71), progressive disease (OR 3,52 95% 0,47-26,57), steroids (OR 6,62 95% 1,5-26,6) and antibiotic treatment for Covid19 (OR 6,88 95% 1,60-29,76) behaved as a risk factors for mortality, but only steroids and antibiotic was statistically significant. In our study, breast cancer patients have high mortality by Covid-19 infection. Age, comorbidities, ECOG >2, progressive disease, and use of antibiotic and steroids are factors for worse prognosis." @default.
- W3202621811 created "2021-10-11" @default.
- W3202621811 creator A5003376190 @default.
- W3202621811 creator A5006913531 @default.
- W3202621811 creator A5006979894 @default.
- W3202621811 creator A5008524277 @default.
- W3202621811 creator A5015274804 @default.
- W3202621811 creator A5033591471 @default.
- W3202621811 creator A5036320402 @default.
- W3202621811 creator A5043471793 @default.
- W3202621811 creator A5049214996 @default.
- W3202621811 creator A5053079188 @default.
- W3202621811 creator A5057427171 @default.
- W3202621811 creator A5066442450 @default.
- W3202621811 creator A5068844567 @default.
- W3202621811 creator A5077289788 @default.
- W3202621811 creator A5080703258 @default.
- W3202621811 creator A5080749594 @default.
- W3202621811 creator A5082722467 @default.
- W3202621811 creator A5088095217 @default.
- W3202621811 creator A5088385234 @default.
- W3202621811 creator A5088710480 @default.
- W3202621811 date "2021-09-01" @default.
- W3202621811 modified "2023-10-18" @default.
- W3202621811 title "1580P Impact of COVID-19 infection on breast cancer patients: Experience in Latin-American country ACHOCC-19B study" @default.
- W3202621811 doi "https://doi.org/10.1016/j.annonc.2021.08.1573" @default.
- W3202621811 hasPublicationYear "2021" @default.
- W3202621811 type Work @default.
- W3202621811 sameAs 3202621811 @default.
- W3202621811 citedByCount "0" @default.
- W3202621811 crossrefType "journal-article" @default.
- W3202621811 hasAuthorship W3202621811A5003376190 @default.
- W3202621811 hasAuthorship W3202621811A5006913531 @default.
- W3202621811 hasAuthorship W3202621811A5006979894 @default.
- W3202621811 hasAuthorship W3202621811A5008524277 @default.
- W3202621811 hasAuthorship W3202621811A5015274804 @default.
- W3202621811 hasAuthorship W3202621811A5033591471 @default.
- W3202621811 hasAuthorship W3202621811A5036320402 @default.
- W3202621811 hasAuthorship W3202621811A5043471793 @default.
- W3202621811 hasAuthorship W3202621811A5049214996 @default.
- W3202621811 hasAuthorship W3202621811A5053079188 @default.
- W3202621811 hasAuthorship W3202621811A5057427171 @default.
- W3202621811 hasAuthorship W3202621811A5066442450 @default.
- W3202621811 hasAuthorship W3202621811A5068844567 @default.
- W3202621811 hasAuthorship W3202621811A5077289788 @default.
- W3202621811 hasAuthorship W3202621811A5080703258 @default.
- W3202621811 hasAuthorship W3202621811A5080749594 @default.
- W3202621811 hasAuthorship W3202621811A5082722467 @default.
- W3202621811 hasAuthorship W3202621811A5088095217 @default.
- W3202621811 hasAuthorship W3202621811A5088385234 @default.
- W3202621811 hasAuthorship W3202621811A5088710480 @default.
- W3202621811 hasBestOaLocation W32026218111 @default.
- W3202621811 hasConcept C121608353 @default.
- W3202621811 hasConcept C126322002 @default.
- W3202621811 hasConcept C156957248 @default.
- W3202621811 hasConcept C201903717 @default.
- W3202621811 hasConcept C203014093 @default.
- W3202621811 hasConcept C2522874641 @default.
- W3202621811 hasConcept C2777813720 @default.
- W3202621811 hasConcept C2777910003 @default.
- W3202621811 hasConcept C2908647359 @default.
- W3202621811 hasConcept C530470458 @default.
- W3202621811 hasConcept C71924100 @default.
- W3202621811 hasConcept C72563966 @default.
- W3202621811 hasConcept C99454951 @default.
- W3202621811 hasConceptScore W3202621811C121608353 @default.
- W3202621811 hasConceptScore W3202621811C126322002 @default.
- W3202621811 hasConceptScore W3202621811C156957248 @default.
- W3202621811 hasConceptScore W3202621811C201903717 @default.
- W3202621811 hasConceptScore W3202621811C203014093 @default.
- W3202621811 hasConceptScore W3202621811C2522874641 @default.
- W3202621811 hasConceptScore W3202621811C2777813720 @default.
- W3202621811 hasConceptScore W3202621811C2777910003 @default.
- W3202621811 hasConceptScore W3202621811C2908647359 @default.
- W3202621811 hasConceptScore W3202621811C530470458 @default.
- W3202621811 hasConceptScore W3202621811C71924100 @default.
- W3202621811 hasConceptScore W3202621811C72563966 @default.
- W3202621811 hasConceptScore W3202621811C99454951 @default.
- W3202621811 hasLocation W32026218111 @default.
- W3202621811 hasLocation W32026218112 @default.
- W3202621811 hasLocation W32026218113 @default.
- W3202621811 hasOpenAccess W3202621811 @default.
- W3202621811 hasPrimaryLocation W32026218111 @default.
- W3202621811 hasRelatedWork W1987215768 @default.
- W3202621811 hasRelatedWork W1995188757 @default.
- W3202621811 hasRelatedWork W2016679923 @default.
- W3202621811 hasRelatedWork W2031086945 @default.
- W3202621811 hasRelatedWork W2052788544 @default.
- W3202621811 hasRelatedWork W2116001782 @default.
- W3202621811 hasRelatedWork W3099665691 @default.
- W3202621811 hasRelatedWork W3120510923 @default.
- W3202621811 hasRelatedWork W3208192759 @default.
- W3202621811 hasRelatedWork W4229900919 @default.
- W3202621811 hasVolume "32" @default.
- W3202621811 isParatext "false" @default.
- W3202621811 isRetracted "false" @default.
- W3202621811 magId "3202621811" @default.
- W3202621811 workType "article" @default.